2,3-bis(4-hydroxyphenyl)-propionitrile has been researched along with Angiogenesis, Pathologic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chao, MP; Guan, J; Hasni, MS; Okret, S; Sander, B; Yakimchuk, K | 1 |
| Pfreundschuh, M; Roemer, K; Römer, K | 1 |
| Collins, F; Esnal-Zufiaurre, A; Giakoumelou, S; Greaves, E; Horne, AW; Saunders, PT | 1 |
3 other study(ies) available for 2,3-bis(4-hydroxyphenyl)-propionitrile and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Inhibition of lymphoma vascularization and dissemination by estrogen receptor β agonists.
Topics: Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Estrogen Receptor beta; Humans; Lymphoma; Male; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Neoplasm Metastasis; Neovascularization, Pathologic; Nitriles; Propionates; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2014 |
How do estrogens control lymphoma?
Topics: Angiogenesis Inhibitors; Animals; Estrogen Receptor beta; Humans; Lymphoma; Male; Neovascularization, Pathologic; Nitriles; Propionates | 2014 |
Estrogen receptor (ER) agonists differentially regulate neuroangiogenesis in peritoneal endometriosis via the repellent factor SLIT3.
Topics: Adolescent; Adult; Animals; Cells, Cultured; Embryo, Mammalian; Endometriosis; Endometrium; Estrogens; Female; Humans; Membrane Proteins; Mice; Mice, Inbred C57BL; Middle Aged; Neovascularization, Pathologic; Neurogenesis; Nitriles; Peritoneal Diseases; Phenols; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Young Adult | 2014 |